财务激励改善哮喘患儿用药依从性的预试验随机对照试验
该预试验随机对照试验纳入32例11-17岁哮喘患儿,评估财务激励对用药依从性的效果与可行性。干预组12周内每完成一次早晚吸入给药获1英镑(最高168英镑),对照组接受常规护理。结果显示干预组中位依从性73.0%高于对照组56.0%,但未达统计学显著(p=0.077),随访期两组依从性均显著下降。
要点
- 财务激励未显著提高哮喘患儿12周用药依从性(73.0% vs 56.0%,p=0.077)。
- 随访期干预组和对照组依从性均显著下降(至39.0%和31.5%)。
- 研究实施面临招募缓慢和技术问题挑战,需改进技术以开展确定性研究。
核心结论
- 在这项小型预试验中,财务激励未能有效维持用药依从性。
- 需要改进技术以开展确定性研究,未来可探索促进财务激励成功的个体特征。
研究设计与样本
- 预试验随机对照试验,使用电子监测设备(EMD)及每日两次提醒测量依从性,设计有患者与公众参与支持。
- 患儿在严重哮喘急性发作急诊就诊后2至12周内招募,共纳入32例11-17岁哮喘患儿,随机分为干预组16例和对照组16例。
- 干预组12周内每完成一次早晨或晚间吸入给药获1英镑(最高168英镑),对照组接受常规护理(使用EMD和提醒)无财务激励。
主要发现
- 32例患儿平均年龄13.4岁(±1.64,SD),65.6%为男性。
- 12周后干预组中位依从性73.0%(范围23.0-89.0%),对照组56.0%(范围7.0-87.0%),差异未达显著(p=0.077)。
- 随访期间干预组依从性显著下降至39.0%(范围0.0-72.0%,p=0.012),对照组显著下降至31.5%(范围3.0-62.0%,p=0.002)。
- 研究实施因招募缓慢和技术问题面临挑战。
临床怎么用
- 本研究为预试验,结果不足以支持在临床实践中常规使用财务激励改善哮喘患儿用药依从性。
- 未来需改进技术并探索个体特征,以确定财务激励在哮喘患儿中的适用性。
局限性
- 样本量小(32例),研究为预试验。
- 招募缓慢和技术问题影响研究实施。
- 财务激励效果未达统计学显著,且依从性在随访期下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess effectiveness and feasibility of financial incentives to improve medication adherence for children and young people (CYP) with asthma. DESIGN: Pilot randomised controlled trial measuring adherence in CYP using an electronic monitoring device (EMD) with twice-daily reminders; design supported by patient and public involvement. SETTING: CYP were recruited between 2 and 12 weeks after attendance at an emergency department (ED) following a severe asthma exacerbation. PATIENTS: CYP aged 11-17 years old with asthma, who were prescribed inhaled corticosteroids for at least 6 months prior to their exacerbation, owned their own smartphone and understood verbal and written English. INTERVENTIONS: Intervention CYP received £1 per complete morning/£1 per complete evening inhaler dose(s) for 12 weeks (max £168). Controls received usual care (with EMD and reminder use) with no financial incentives. MAIN OUTCOME MEASURES: adherence, asthma control and psychological outcomes. Feasibility assessed by recruitment, randomisation and intervention delivery indicators. RESULTS: 32 CYP (mean age: 13.4 years (±1.64, SD); 65.6% male) were enrolled; 16 randomised to intervention. After 12 weeks, those who received financial incentives had higher median adherence (73.0%, range: 23.0-89.0%), compared with control (56.0%, range: 7.0-87.0%); this did not reach significance (p=0.077). During follow-up, intervention and control adherence significantly decreased (to 39.0%, range: 0.0-72.0%, p=0.012 and 31.5%, range: 3.0-62.0%, p=0.002, respectively). Study implementation was challenging due to slow recruitment and technological issues. CONCLUSIONS: In this small pilot study, financial incentives were not effective in sustaining adherence. Improved technology is necessary for a definitive study. Future work could explore individual characteristics that contribute to successful financial incentive use in CYP. TRIAL REGISTRATION NUMBER: NCT05322044.
引用
- Hine J, Bush A, De Simoni A, et al. Financial INcentives to improve Asthma (FINA): a pilot RCT to improve medication adherence for children and young people with asthma. Arch Dis Child. 2026. PMID: 42843968. doi:10.1136/archdischild-2026-331320
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。